RU2005105766A - WATER-GLYCERINE COMPLEX (2,3-DIOXIPROPYL) ORTHO-TITANATE-SILICATE "KREMNELIFE" AND PHARMACEUTICAL COMPOSITION ON ITS BASIS - Google Patents

WATER-GLYCERINE COMPLEX (2,3-DIOXIPROPYL) ORTHO-TITANATE-SILICATE "KREMNELIFE" AND PHARMACEUTICAL COMPOSITION ON ITS BASIS Download PDF

Info

Publication number
RU2005105766A
RU2005105766A RU2005105766/04A RU2005105766A RU2005105766A RU 2005105766 A RU2005105766 A RU 2005105766A RU 2005105766/04 A RU2005105766/04 A RU 2005105766/04A RU 2005105766 A RU2005105766 A RU 2005105766A RU 2005105766 A RU2005105766 A RU 2005105766A
Authority
RU
Russia
Prior art keywords
water
dioxipropyl
ortho
titanate
silicate
Prior art date
Application number
RU2005105766/04A
Other languages
Russian (ru)
Other versions
RU2306317C2 (en
Inventor
Владимир Сергеевич Жернаков (RU)
Владимир Сергеевич Жернаков
Original Assignee
Владимир Сергеевич Жернаков (RU)
Владимир Сергеевич Жернаков
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Владимир Сергеевич Жернаков (RU), Владимир Сергеевич Жернаков filed Critical Владимир Сергеевич Жернаков (RU)
Priority to RU2005105766/04A priority Critical patent/RU2306317C2/en
Publication of RU2005105766A publication Critical patent/RU2005105766A/en
Application granted granted Critical
Publication of RU2306317C2 publication Critical patent/RU2306317C2/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (2)

1. Водно-глицериновый комплекс на основе (2,3-диоксипропил)орто-титанат-силиката, состав которого отвечает формуле
Figure 00000001
, полученный взаимодействием бутилортотитаната и этилортосиликата с глицерином в мольном соотношении 1:1:20 соответственно при температуре 100-120°С в вакууме с удалением образующейся смеси этилового и бутилового спиртов, последующим добавлением подкисленной до рН 2,5-3,5 воды и выдержкой при температуре не выше 85°С не более 1,5 ч.1. A water-glycerin complex based on (2,3-dioxipropyl) ortho-titanate silicate, the composition of which corresponds to the formula
Figure 00000001
obtained by reacting butylorthotitanate and ethylorthosilicate with glycerol in a molar ratio of 1: 1: 20, respectively, at a temperature of 100-120 ° C in vacuum, removing the resulting mixture of ethyl and butyl alcohols, then adding acidified water to pH 2.5-3.5 and holding at a temperature not exceeding 85 ° C no more than 1.5 hours 2. Фармацевтическая композиция, содержащая активное вещество и носитель, которая в качестве носителя содержит водно-глицериновый комплекс на основе (2,3-диоксипропил)орто-титанат-силиката, состав которого отвечает формуле
Figure 00000001
, полученного взаимодействием бутилортотитаната и этилортосиликата с глицерином в мольном соотношении 1:1:20 соответственно при температуре 100-120°С в вакууме с удалением образующейся смеси этилового и бутилового спиртов, последующим добавлением подкисленной до рН 2,5-3,5 воды и выдержкой при температуре не выше 85°С не более 1,5 ч при следующем соотношении компонентов, мас.%:2. A pharmaceutical composition containing an active substance and a carrier, which as a carrier contains a water-glycerin complex based on (2,3-dioxipropyl) ortho-titanate silicate, the composition of which corresponds to the formula
Figure 00000001
obtained by reacting butylorthotitanate and ethylorthosilicate with glycerol in a molar ratio of 1: 1: 20, respectively, at a temperature of 100-120 ° C in vacuum, removing the resulting mixture of ethyl and butyl alcohols, then adding acidified water to pH 2.5-3.5 and holding at a temperature not exceeding 85 ° C no more than 1.5 hours in the following ratio of components, wt.%: активное вещество 0,01-10,00active substance 0.01-10.00 носитель Остальноеcarrier Else
RU2005105766/04A 2005-03-01 2005-03-01 Water-glycerol complex based on (2,3-dioxypropyl)orthotitanate-silicate and pharmaceutical composition RU2306317C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2005105766/04A RU2306317C2 (en) 2005-03-01 2005-03-01 Water-glycerol complex based on (2,3-dioxypropyl)orthotitanate-silicate and pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2005105766/04A RU2306317C2 (en) 2005-03-01 2005-03-01 Water-glycerol complex based on (2,3-dioxypropyl)orthotitanate-silicate and pharmaceutical composition

Publications (2)

Publication Number Publication Date
RU2005105766A true RU2005105766A (en) 2006-08-10
RU2306317C2 RU2306317C2 (en) 2007-09-20

Family

ID=37059298

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2005105766/04A RU2306317C2 (en) 2005-03-01 2005-03-01 Water-glycerol complex based on (2,3-dioxypropyl)orthotitanate-silicate and pharmaceutical composition

Country Status (1)

Country Link
RU (1) RU2306317C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2458929C1 (en) * 2011-04-15 2012-08-20 Учреждение Российской академии наук Институт органического синтеза им. И.Я. Постовского Уральского отделения РАН Silicon-titanium-containing polyol derivatives and hydrogels based thereon

Also Published As

Publication number Publication date
RU2306317C2 (en) 2007-09-20

Similar Documents

Publication Publication Date Title
RU2008139905A (en) PHARMACEUTICAL COMPOSITION FOR EXTERNAL USE
MY154484A (en) Treatment of virally induces lesions
AR048599A1 (en) ANTI-P-SELECTINE ANTIBODIES
EA200900676A1 (en) HEPATITIS C VIRUS INHIBITORS
TR200401029T4 (en) Acylphenyl-urea derivatives, manufacturing methods and their use as pharmaceuticals
BR0311693A (en) O-desmethyl-venlafaxine salt
MA29619B1 (en) 1,4-BENZOTHIAZEPINE 1,1-OCIOXIDE DERIVATIVE, PROCESS FOR PREPARING SAME, MEDICAMENTS COMPRISING THE SAME, AND USE THEREOF AS HYPOLIPIDEMIATING
DE502005008631D1 (en) DERMATOLOGICAL PREPARATIONS
EA200701810A1 (en) ISOXAZOLINE DERIVATIVE AND A NEW METHOD FOR ITS PREPARATION
JP2004520453A5 (en)
GB0412769D0 (en) Organic compounds
CY1108804T1 (en) METHOD OF PREPARATION OF 4B-AMINO-4'-DEMETHYL-4-DESESOPYPOPHYLOTOXINE.
WO2007007207A8 (en) Pharmaceutical compositions of 3, 5 -bis (arylidene) -4 -piperidones and analogues there of for modulating cell proliferation
ATE493110T1 (en) COSMETIC COMPOSITION FOR STIMULATING THE SYNTHESIS OF BASAL MEMBRANE PROTEINS
RU2005114653A (en) METHOD FOR PRODUCING 5- [ORTO- (STEAM -) - HYDROXYPHENYL] -1,3,5-Dithiazines
DK1970372T3 (en) Salts of 9-oxoacridine-10-acetic acid with 1-alkylamino-1-deoxy-polyols
RU2005105766A (en) WATER-GLYCERINE COMPLEX (2,3-DIOXIPROPYL) ORTHO-TITANATE-SILICATE "KREMNELIFE" AND PHARMACEUTICAL COMPOSITION ON ITS BASIS
AR073871A1 (en) FULVESTRAN INTERMEDIARY
RU2009138470A (en) COMPOSITION FOR EXTERNAL USE ON SKIN
JP2006517932A5 (en)
EA200701622A1 (en) POLYMERIC COMPOSITIONS AND THEIR APPLICATION FOR OBTAINING COMPOSITIONS OF ACTIVE OR EFFECTIVE SUBSTANCE
DE69920039D1 (en) QUINAPRIL MAGNESIUM CONTAINING, PHARMACEUTIC EFFECTIVE COMPOSITION
EA200700580A1 (en) TESTOSTERONE GELS, INCLUDING PROPYLENE GLYCOL AS A PERMEABILITY POWER
RU2002135455A (en) SEQUENCE HEPTAPEPTID MET-GLU-HIS-PHE-PRO-GLY-PRO WITH NEUROPROTECTIVE ACTIVITY AND PHARMACEUTICAL COMPOSITION ON ITS BASIS
ATE356118T1 (en) MEDICINAL PRODUCTS CONTAINING MOEXIPRIL MAGNESIUM

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20061123

FZ9A Application not withdrawn (correction of the notice of withdrawal)

Effective date: 20061123

MM4A The patent is invalid due to non-payment of fees

Effective date: 20130302